BB's Stock Haven

[million]

RHEO Cramer excerpt: The Eyes Have It
It's time to buy the greatest medical stock you've never heard, Jim Cramer told his "Mad Money" TV show viewers Thursday, and that stock is OccuLogix (RHEO:Nasdaq - news - research - Cramer's Take).

People aren't just paying for vanity as they age, they'd also like to be able to see, Cramer said. But those who suffer from age-related macular degeneration are losing their eyesight.

There are treatments on the market from companies such as Genentech (DNA:NYSE - news - research - Cramer's Take) for wet macular degeneration, but there's really nothing out there for dry macular degeneration, which usually comes first.

But OccuLogix has a blood filtration procedure to treat dry macular degeneration, and Cramer said that this could mean mad money.

Cramer said there were no vitamin plays that could offer the kind of returns OccuLogix may someday unleash, but he added that the stock was speculative. So Cramer emphasized that it would be important to use limit orders.